Heather A. Smith

A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

E. Estey, M. Othus, R. Walter, 2016 .

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.

E. Estey, F. Appelbaum, R. Walter, 2020, Blood advances.

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

E. Estey, M. Othus, R. Walter, 2018, Haematologica.

High Throughput Drug Synergy Testing in a Clinical Trial of Panobinostat, Carfilzomib, Dexamethasone to Define Response Biomarkers for Relapsed/Refractory Multiple Myeloma

T. Gooley, D. Coffey, P. Becker, 2019, Blood.

A case of indolent AML with five-year survival without treatment

E. Estey, Evandro D Bezerra, Heather A. Smith, 2018, Leukemia & lymphoma.